To evaluate the conditional intravesical recurrence (IVR)-free (IVRF) survival rate in patients with upper tract urothelial carcinoma (UTUC) who had no history of bladder cancer and no concomitant bladder cancer.
To evaluate the conditional intravesical recurrence (IVR)-free (IVRF) survival rate in patients with upper tract urothelial carcinoma (UTUC) who had no history of bladder cancer and no concomitant bladder cancer.